BRCA1 and cancer: In HGSOC cells with mutant BRCA1/2 or other defective HR genes, the inhibition of PARP forces cancer cells to rely on error-prone repair DNA pathways or otherwise unrepaired damage persist into mitosis, leading to the rapid accumulation of mutations, genomic instability, and eventual cell death.